Production of well characterized challenge material (WCCM) of BSL-3/4 viruses.
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
American Type Culture Collection UEI KT4MLLHK99V6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,192,601
Award facts
- Contract value 8% obligated
-
- $1,192,601.00 Current, with exercised options
- $15,466,765.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Manassas, VA 20110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $580,044 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $612,557 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $15.5 million to American Type Culture Collection (ATCC) on February 29, 2024, for the production of well-characterized challenge material (WCCM) of Biosafety Level 3 and 4 viruses. This delivery order is issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The work will be performed at ATCC's Manassas, Virginia facility, with an ultimate completion date of April 24, 2026. The contract employs a cost-plus-fixed-fee pricing structure and was awarded without a set-aside designation, indicating ATCC competed through open competition.
ATCC, a nonprofit biological resource center, is a critical provider of specialized biological materials and services to federal agencies. This award supports NIAID's infectious disease research and medical countermeasure development initiatives by leveraging ATCC's expertise in producing, authenticating, and characterizing high-containment viral materials. The contract aligns with ATCC's broader portfolio of federal work with NIAID and other agencies, including significant IDIQ contracts for biological materials repository services, preclinical infectious disease models, and related research support. Challenge materials of this nature are essential for evaluating the efficacy and safety of potential therapeutics and vaccines against dangerous pathogens.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to American Type Culture Collection by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 29, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $1,192,601 on 75N93024F00001. Its potential value, with all options, is $15,466,765.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93019D00002, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award